| Year |
Citation |
Score |
| 2023 |
Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, et al. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Annals of Internal Medicine. PMID 36940444 DOI: 10.7326/M22-3350 |
0.368 |
|
| 2020 |
Evon DM, Lin HS, Khalili M, Fontana RJ, Yim C, Wahed AS, Fried MW, Hoofnagle JH. Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis. Alimentary Pharmacology & Therapeutics. PMID 31943262 DOI: 10.1111/Apt.15618 |
0.34 |
|
| 2019 |
Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. The American Journal of Gastroenterology. PMID 31658127 DOI: 10.14309/Ajg.0000000000000400 |
0.325 |
|
| 2019 |
Navarro VJ, Belle SH, D'Amato M, Adfhal N, Brunt EM, Fried MW, Reddy KR, Wahed AS, Harrison S. Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial. Plos One. 14: e0221683. PMID 31536511 DOI: 10.1371/Journal.Pone.0221683 |
0.312 |
|
| 2019 |
Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults. Hepatology (Baltimore, Md.). PMID 31220357 DOI: 10.1002/Hep.30825 |
0.302 |
|
| 2019 |
Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, et al. Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B. Plos Pathogens. 15: e1007715. PMID 30998783 DOI: 10.1371/Journal.Ppat.1007715 |
0.32 |
|
| 2019 |
Sterling RK, Wahed A, Bisceglie AD, Lisker-Melman M, Wong D, Lee WM. Su1514 – Differences in Clinical and Serologic Characterization of Acute and Chronic Hepatitis B in North America: Analysis of the Hepatitis B Research Network Gastroenterology. 156: S-1291. DOI: 10.1016/S0016-5085(19)40229-1 |
0.302 |
|
| 2018 |
Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. The American Journal of Gastroenterology. PMID 30410040 DOI: 10.1038/S41395-018-0409-9 |
0.307 |
|
| 2018 |
Chen LW, Yavuz I, Cheng Y, Wahed AS. Cumulative incidence regression for dynamic treatment regimens. Biostatistics (Oxford, England). PMID 30371745 DOI: 10.1093/Biostatistics/Kxy062 |
0.312 |
|
| 2017 |
Jiang Z, Liu Y, Wahed AS, Molenberghs G. Joint modeling of multiple ordinal adherence outcomes via generalized estimating equations with flexible correlation structure. Statistics in Medicine. PMID 29235127 DOI: 10.1002/Sim.7560 |
0.328 |
|
| 2017 |
Hassan MA, Kim WR, Li R, Smith CI, Fried MW, Sterling RK, Ghany MG, Wahed AS, Ganova-Raeva LM, Roberts LR, Lok ASF. Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B. American Journal of Epidemiology. 1-11. PMID 28525625 DOI: 10.1093/Aje/Kwx064 |
0.33 |
|
| 2017 |
Sterling RK, Wahed A, Khalili M, Sulkowski MS, Jain M, Wong D, Lisker-Melman M, Ghany MG, Chung RT, Kleiner D. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Coinfected with Human Immunodeficiency Virus (HIV) Gastroenterology. 152: S27. DOI: 10.1016/S0016-5085(17)30460-2 |
0.31 |
|
| 2016 |
Xu Y, Müller P, Wahed AS, Thall PF. Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times. Journal of the American Statistical Association. 111: 921-935. PMID 28018015 DOI: 10.1080/01621459.2015.1086353 |
0.308 |
|
| 2016 |
Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Digestive Diseases and Sciences. PMID 26831489 DOI: 10.1007/S10620-015-4006-0 |
0.328 |
|
| 2016 |
Yavuz I, Chng Y, Wahed AS. Estimating the cumulative incidence function of dynamic treatment regimes Journal of the Royal Statistical Society: Series a (Statistics in Society). 181: 85-106. DOI: 10.1111/Rssa.12250 |
0.318 |
|
| 2015 |
Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, et al. HBV-specific and global T-cell dysfunction in chronic hepatitis B. Gastroenterology. PMID 26684441 DOI: 10.1053/J.Gastro.2015.11.050 |
0.302 |
|
| 2015 |
Ogbagaber SB, Karp J, Wahed AS. Design of sequentially randomized trials for testing adaptive treatment strategies. Statistics in Medicine. PMID 26412033 DOI: 10.1002/Sim.6747 |
0.309 |
|
| 2015 |
Tang X, Wahed AS. Cumulative Hazard Ratio Estimation for Treatment Regimes in Sequentially Randomized Clinical Trials. Statistics in Biosciences. 7: 1-18. PMID 26085847 DOI: 10.1007/S12561-013-9089-6 |
0.319 |
|
| 2015 |
Tang X, Wahed AS. Pattern-mixture-type Estimation and Testing of Neuroblastoma Treatment Regimes. Journal of Statistical Theory and Practice. 9: 266-287. PMID 25750601 DOI: 10.1080/15598608.2013.878888 |
0.335 |
|
| 2013 |
Wahed AS, Thall PF. Evaluating Joint Effects of Induction-Salvage Treatment Regimes on Overall Survival in Acute Leukemia. Journal of the Royal Statistical Society. Series C, Applied Statistics. 62: 67-83. PMID 24014891 DOI: 10.1111/J.1467-9876.2012.01048.X |
0.317 |
|
| 2013 |
Kidwell KM, Wahed AS. Weighted log-rank statistic to compare shared-path adaptive treatment strategies. Biostatistics (Oxford, England). 14: 299-312. PMID 23178734 DOI: 10.1093/Biostatistics/Kxs042 |
0.3 |
|
| 2012 |
Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. Jama. 308: 274-82. PMID 22797645 DOI: 10.1001/Jama.2012.8265 |
0.332 |
|
| 2012 |
Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. Journal of Hepatology. 57: 946-52. PMID 22760009 DOI: 10.1016/J.Jhep.2012.06.030 |
0.337 |
|
| 2012 |
Ko JH, Wahed AS. Up-front versus sequential randomizations for inference on adaptive treatment strategies. Statistics in Medicine. 31: 812-30. PMID 22362642 DOI: 10.1002/Sim.4473 |
0.308 |
|
| 2012 |
Reddy KR, Belle SH, Fried MW, Afdhal N, Navarro VJ, Hawke RL, Wahed AS, Doo E, Meyers CM. Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C. Clinical Trials (London, England). 9: 102-12. PMID 22058086 DOI: 10.1177/1740774511427064 |
0.332 |
|
| 2011 |
Schrieber SJ, Hawke RL, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Meyers CM, Doo E, Fried MW. Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 2182-90. PMID 21865319 DOI: 10.1124/Dmd.111.040212 |
0.329 |
|
| 2011 |
Conjeevaram HS, Wahed AS, Afdhal N, Howell CD, Everhart JE, Hoofnagle JH. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology. 140: 469-77. PMID 21070775 DOI: 10.1053/J.Gastro.2010.11.002 |
0.325 |
|
| 2011 |
Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort. Journal of Viral Hepatitis. 18: e144-52. PMID 21070504 DOI: 10.1111/J.1365-2893.2010.01394.X |
0.334 |
|
| 2011 |
Tang X, Wahed AS. Comparison of treatment regimes with adjustment for auxiliary variables Journal of Applied Statistics. 38: 2925-2938. DOI: 10.1080/02664763.2011.573541 |
0.309 |
|
| 2010 |
Miyahara S, Wahed AS. Weighted Kaplan-Meier estimators for two-stage treatment regimes. Statistics in Medicine. 29: 2581-91. PMID 20799259 DOI: 10.1002/Sim.4020 |
0.305 |
|
| 2010 |
Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ. Associations between serum lipids and hepatitis C antiviral treatment efficacy. Hepatology (Baltimore, Md.). 52: 854-63. PMID 20690192 DOI: 10.1002/Hep.23796 |
0.324 |
|
| 2010 |
Donlin MJ, Cannon NA, Aurora R, Li J, Wahed AS, Di Bisceglie AM, Tavis JE. Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients. Plos One. 5: e9032. PMID 20140258 DOI: 10.1371/Journal.Pone.0009032 |
0.329 |
|
| 2010 |
Hawke RL, Schrieber SJ, Soule TA, Wen Z, Smith PC, Reddy KR, Wahed AS, Belle SH, Afdhal NH, Navarro VJ, Berman J, Liu QY, Doo E, Fried MW. Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis C. Journal of Clinical Pharmacology. 50: 434-49. PMID 19841158 DOI: 10.1177/0091270009347475 |
0.317 |
|
| 2010 |
Wahed AS. Inference for two-stage adaptive treatment strategies using mixture distributions Journal of the Royal Statistical Society. Series C: Applied Statistics. 59: 1-18. DOI: 10.1111/J.1467-9876.2009.00679.X |
0.31 |
|
| 2009 |
Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. The New England Journal of Medicine. 361: 445-54. PMID 19641201 DOI: 10.1056/Nejmoa0901836 |
0.306 |
|
| 2009 |
Feng W, Wahed AS. Sample size for two-stage studies with maintenance therapy. Statistics in Medicine. 28: 2028-41. PMID 19382105 DOI: 10.1002/Sim.3593 |
0.308 |
|
| 2009 |
Hoofnagle JH, Wahed AS, Brown RS, Howell CD, Belle SH. Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. The Journal of Infectious Diseases. 199: 1112-20. PMID 19284286 DOI: 10.1086/597384 |
0.342 |
|
| 2009 |
Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H. Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C. Antimicrobial Agents and Chemotherapy. 53: 615-21. PMID 18852273 DOI: 10.1128/Aac.00947-08 |
0.325 |
|
| 2009 |
Wahed AS. Estimation of survival quantiles in two-stage randomization designs Journal of Statistical Planning and Inference. 139: 2064-2075. DOI: 10.1016/J.Jspi.2008.09.003 |
0.319 |
|
| 2008 |
Howell CD, Dowling TC, Paul M, Wahed AS, Terrault NA, Taylor M, Jeffers L, Hoofnagle JH. Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 6: 575-83. PMID 18407798 DOI: 10.1016/J.Cgh.2008.02.035 |
0.346 |
|
| 2008 |
Golden-Mason L, Klarquist J, Wahed AS, Rosen HR. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. Journal of Immunology (Baltimore, Md. : 1950). 180: 3637-41. PMID 18322167 DOI: 10.4049/Jimmunol.180.6.3637 |
0.312 |
|
| 2008 |
Schrieber SJ, Soule TA, Wen Z, Wahed AS, Smith PC, Fried MW, Reddy KR, Navarro VJ, Afdhal N, Belle SH, Berman J, Liu Q, Doo E, Hawke RL. W1011 Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Silymarin (SM) Following Chronic Dosing in Patients with Chronic Hepatitis C (HCV) Gastroenterology. 134: A-831. DOI: 10.1016/S0016-5085(08)63887-1 |
0.314 |
|
| 2007 |
Brodsky LI, Wahed AS, Li J, Tavis JE, Tsukahara T, Taylor MW. A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients. Plos One. 2: e584. PMID 17589564 DOI: 10.1371/Journal.Pone.0000584 |
0.338 |
|
| 2007 |
Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A, Tong X, Rhodes S, Su X, Whelan RM, Fontana RJ, Ghany MG, Borg B, Liang TJ, Yang H, et al. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology (Baltimore, Md.). 46: 74-83. PMID 17526009 DOI: 10.1002/Hep.21636 |
0.326 |
|
| 2007 |
Donlin MJ, Cannon NA, Yao E, Li J, Wahed A, Taylor MW, Belle SH, Di Bisceglie AM, Aurora R, Tavis JE. Pretreatment sequence diversity differences in the full-length hepatitis C virus open reading frame correlate with early response to therapy. Journal of Virology. 81: 8211-24. PMID 17522222 DOI: 10.1128/Jvi.00487-07 |
0.324 |
|
| 2007 |
Smith SR, Wahed AS, Kelley SS, Conjeevaram HS, Robuck PR, Fried MW. Assessing the validity of self-reported medication adherence in hepatitis C treatment. The Annals of Pharmacotherapy. 41: 1116-23. PMID 17519299 DOI: 10.1345/Aph.1K024 |
0.312 |
|
| 2007 |
Conjeevaram HS, Kleiner DE, Everhart JE, Hoofnagle JH, Zacks S, Afdhal NH, Wahed AS. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology (Baltimore, Md.). 45: 80-7. PMID 17187406 DOI: 10.1002/Hep.21455 |
0.345 |
|
| 2004 |
Wahed AS, Tsiatis AA. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics. 60: 124-33. PMID 15032782 DOI: 10.1111/J.0006-341X.2004.00160.X |
0.31 |
|
| Show low-probability matches. |